ロード中...
Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
PURPOSE: Among a cohort of postmenopausal breast cancer survivors, we aimed to compare the risk of dementia associated with aromatase inhibitor (AI) therapy versus tamoxifen. METHODS: Using UK primary care electronic health records, we identified 14,214 postmenopausal breast cancer survivors (aged ≥...
保存先:
| 出版年: | J Cancer Surviv |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776493/ https://ncbi.nlm.nih.gov/pubmed/31321612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11764-019-00782-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|